Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThree new update dates were added to the study record's history in April 2026, and three older update dates from February and March 2026 were removed. The changes reflect administrative updates to the record rather than alterations to the study design, eligibility criteria, or results.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a maintenance or technical release without altering the displayed clinical study information.SummaryDifference0.0%

- Check26 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows administrative revision updates including a new revision (v3.5.0) with recent update dates (2026-02-26, 2026-03-18). The previous revision history (v3.4.3) and its dates appear to have been removed.SummaryDifference0.2%

- Check68 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this appears to be a minor system/UI update with no changes to study content, eligibility, or primary data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.